Navigation Links
'TUG' Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients
Date:6/9/2009

DALLAS, June 9 /PRNewswire-USNewswire/ -- Interventional cardiac catheterization procedures are one of the most effective treatments for peripheral vascular disease (PVD), a looming health crisis as the U.S. population ages and more Americans battle obesity. But the procedures are not an option for millions of Americans with PVD who also have kidney problems or allergies to the contrast dye used during the procedures.

As a possible new option for these patients, Dr. Tony Das, an interventional cardiologist at Texas Health Presbyterian Hospital Dallas, recently demonstrated a unique procedure that clears femoral artery blockages without the use of contrast dye or X-ray radiation.

"We're always looking for new and innovative ways to better care for patients with this debilitating condition," Dr. Das said. "This procedure could one day be something we offer people who are not suitable candidates for other interventional procedures."

Called TUG (transcutaneous ultrasound guided vascular intervention), the procedure involves using an ultrasound device on top of the patient's skin to produce images of the arteries and guide a tiny wire that travels inside the arteries to clear the blockage. A balloon on the end of the wire is inflated to open the artery and a stent placed in the artery to keep it open.

"With the prevalence of diabetes and obesity among an already aging population, the challenges facing those involved in the diagnosis and treatment of peripheral vascular disease increase by the minute," Dr. Das said. "It's a problem that will increasingly challenge medical experts around the country in coming years."

PVD is a common condition affecting more than 10 million adults in the United States. The condition is a disease of blood vessels outside the heart and brain characterized by a narrowing of vessels that carry blood to the legs, arms, stomach and kidneys. The condition causes lower-leg tissue damage, non-healing wounds, blood clots and limb loss.

"Currently, PVD patients with kidney problems or allergies to contrast dye can only be treated with medications or open surgery, which carries a higher risk for complications," said Jon Gardner, administrative director of the Heart & Vascular Service Line at Texas Health Dallas. "Innovative new procedures like Dr. Das' technique could provide hope to these patients."


'/>"/>
SOURCE Texas Health Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Top Book on Cosmetic Surgery Anesthesia to be Released in Portuguese in Brazil, World Leader in Cosmetic Surgery
2. Varian Medical Systems Introduces Fast and Precise Brachytherapy Planning System at GEC-ESTRO in Portugal
3. Misonix Announces New HIFU Distribution Agreement For Portugal
4. Misonix Announces New Distribution Agreement for Portugal
5. Portuguese scientists discover new mechanism that regulates formation of blood vessels
6. Chiltern Announces New Expansion in Portugal
7. Tug of war in the cells
8. The Tug McGraw Foundation Announces 2007 Fundraising Gala
9. Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options
10. Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas
11. Abbotts XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, Real World Patients in SPIRIT V Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/25/2017)... Marietta, GA (PRWEB) , ... April 25, 2017 ... ... implant and instrument solutions, announces the continuation of its strategic partnership with and ... surgeons in developing nations in the safe and effective management of complex spine ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The Santana Telehealth ... ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 ... Project for using telemedicine to improve the lives of the poor and underserved in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: